
Please try another search
Investing.com -- Novo Nordisk A/S (CSE:NOVOb) shares fell over 2% on Monday after full Phase III data for its obesity drug CagriSema, presented at the American Diabetes Association (ADA)...
Investing.com -- The American College of Cardiology released new recommendations on Friday stating that millions more Americans should be taking weight-loss drugs to prevent heart disease. The...
Investing.com - U.S. stock futures soar following the unveiling of a substantial lowering in tariffs between the U.S. and China. The deal helps to underpin optimism for a softening in a recent trade...
Investing.com -- Novo Nordisk (NYSE:NVO) A/S (NOVO_B) on Monday reported positive results from the REAL8 Phase 3 Basket Study of its once-weekly Sogroya (somapacitan) treatment for children with...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review